Inflammatory and mechanical complications associated with 3 years of up to 30 nights of continuous wear of lotrafilcon A silicone hydrogel lenses

Eye and Contact Lens

Volumn 33, Issue 4, 2007, Pages 191-195

  Donshik, Peter ^a   Long, Bill ^b   Dillehay, Sally M ^b   Bergenske, Peter ^b   Barr, Joseph T ^c   Secor, Glenda ^d   Yoakum, John ^e   Chalmers, Robin L ^d  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b CIBA Vision Corporation   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Groat Eyecare Associates ^*  (United States)

^e Groat Eyecare Associates   (United States)

Author keywords

Complications; Inflammation; Long term results; Mechanical; Silicone hydrogel lenses

Indexed keywords

LOTRAFILCON A; SILICONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; DEVICE; FEMALE; FOLLOW UP; HUMAN; HYDROGEL; KERATITIS; MALE; MULTICENTER STUDY; PAPILLARY CONJUNCTIVITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOFT CONTACT LENS; TREATMENT DURATION;

EID: 34547118318     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e31802cc275     Document Type: Article

References (21)

1. Fonn D, duToit R, Vega JA, et al. Sympathetic swelling response of the control eye to soft lenses in the other eye. Invest Ophthalmol Vis Sci 1999;13 3116-3121.
2. Keay L, Sweeney DF, Jalbert I, et al. Microcyst response to high Dk/t silicone hydrogel contact lenses. Optom Vis Sci 2000;77:582-585.
3. Dumbleton K, Chalmers R, Richter D, et al. Vascular response to extended wear of hydrogel lenses with high and low oxygen permeability. Optom Vis Sci 2001;78:147-151.
4. Papas EB, Vajdic CM, Austen R, et al. High-oxygen-transmissibility soft contact lenses do not induce limbal hyperaemia. Curr Eye Res 1997;16:942-948.
5. Papas EB. The role of hypoxia in the limbal vascular response to soft contact lens wear. Eye Contact Lens 2003;29:S72-S74.
6. McNally JJ, Chalmers RL, McKenney CD, et al. Risk factors for corneal infiltrative events with 30 night continuous wear of silicone hydrogel lenses. Eye Contact Lens 2003;29:S153-S156.
7. Summary of Safety and Effectiveness Data. PureVision (Balafilcon A) Soft Contact Lenses - P980006/S004B. 10-12-2001. Rockville, MD, U.S. Food and Drug Administration.
8. Schein OD, McNally JJ, Katz J, et al. The incidence of microbial keratitis among wearers of a 30-day silicone hydrogel extended-wear contact lens. Ophthalmology 2005;112:2172-2179.
9. Chalmers RL, Dillehay S, Long B, et al. Impact of previous extended and daily wear schedules on signs and symptoms with high Dk lotrafilcon A lenses. Optom Vis Sci 2005;82:549-554.
10. Bergenske P, Long B, Dillehay S, et al. Long term clinical results: 3 years of up to 30-night continuous wear of lotrafilcon A silicone hydrogel and daily wear of low-Dk/t hydrogel lenses. Eye Contact Lens 2007;33:74-80.
11. Stern J, Wong R, Naduvilath TJ, et al. Comparison of the performance of 6- or 30-night extended wear schedules with silicone hydrogel lenses over 3 years. Optom Vis Sci 2004;81:398-406.
12. Efron N. Grading scales for contact lens complications. In: Efron N, ed. Contact Lens Complications. Oxford, Butterworth-Heinemann, 2004, pp 239-343.
13. Holden BA, Sankaridurg PR, Jalbert I. Adverse events and infections: which ones and how many? In: Sweeney DF, ed. Silicone Hydrogels: The Rebirth of Continuous Wear Contact Lenses. Oxford, Butterworth-Heinemann, 2000, pp 168-206.
14. Nilsson SEG. Seven-day extended wear and 30-day continuous wear of high oxygen transmissibility soft silicone hydrogel contact lenses: A randomized 1-year study of 504 patients. CLAO J 2001;27:125-136.
15. Brennan NA, Coles MLC, Comstock TL, et al. A 1-year prospective clinical trial of balafilcon A (PureVision) silicone-hydrogel contact lenses used on a 30-day continuous wear schedule. Ophthalmology 2002;109:1172-1177.
16. Skotnitsky C, Sankaridurg PR, Sweeney DF, et al. General and local contact lens induced papillary conjunctivitis (CLPC). Clin Exp Optom 2002;85:193-197.
17. FDA PMA Approved Package Insert for Focus NIGHT & DAY (Lotrafilcon A) lenses, CIBA Vision Corporation PMA P010019, October 2001.
18. Brennan NA, Coles M-L C, Jaworski A, et al. Proposed practice guidelines for continuous contact lens wear. Clin Exp Optom 2001;84:71-77.
19. Summary of Safety and Effectiveness Data. Focus NIGHT & DAY (Lotrafilcon A) Soft Contact Lenses - P010019. 6-10-2002. Rockville, MD, U.S. Food and Drug Administration.
20. Sankaridurg PR, Sharma S, Willcox M, et al. Colonization of hydrogel lenses with Streptococcus pneumoniae: Risk of development of corneal infiltrates. Cornea 1999;18:289-295.
21. Jones L, Senchyna M, Glasier M, et al. Lysozyme and lipid deposition on silicone hydrogel lens materials. Eye Contact Lens 2003;29:S75-S79.